EGF RESPONSIVE GENES WHICH REGULATE TUMOR CELL GROWTH
EGF RESPONSIVE GENES WHICH REGULATE TUMOR CELL GROWTH
批准号:
3183918
负责人:
Carol L. MacLeod
金额:
$13.11万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-04-15 至 1990-03-31
关键词:
affinity chromatography bacteriophage lambda cell growth regulation clone cells epidermal growth factor flow cytometry gene expression genetic library genetic manipulation genetic recombination hormone receptor hormone regulation /control mechanism human tissue messenger RNA molecular cloning natural gene amplification neoplasm /cancer genetics neoplastic growth nucleic acid probes nucleic acid sequence oncogenes radiotracer
中文摘要
表皮生长因子(EGF)和其他
多肽激素对细胞生长控制的影响尚不清楚。
大多数分离和鉴定EGF反应基因的努力已经
重点放在EGF反应的早期阶段。然而,
最早的反应不足以引起增长反应
由于EGF必须持续存在较长时间
(超过6-12小时)在承诺发生之前。在这段时间里
这些细胞经历了大量的代谢变化。它有
事实证明,很难区分哪些事件涉及
从承诺所需的细胞激活,或
刺激细胞分裂。为了避免这个问题,从基因上讲
生长反应不同的相关克隆细胞系
EGF(刺激、无反应或抑制)将被用来分离
EGF反应基因的cDNA。尽管生物反应
对EGF在每种细胞类型中的早期反应是不同的
EGF诱导的克隆在差异反应中相似
细胞系;例如表皮生长因子受体在结合方面是相似的。
与EGF的亲和力,引发酪氨酸磷酸化的程度
由激素和受体的速度和程度决定的
内部化。具有代表性的大分子lambda gt10基因
用每个细胞克隆合成的cdna构建文库
在定义的时间间隔内使用EGF处理的类型。图书馆将是
消减杂交制备的cDNAs探针筛选
以丰富每个细胞的EGF反应的特异性序列
克隆类型。将使用消减杂交cdna探针
以丰富可归类的EGF响应序列
如下:1)在每种克隆细胞类型中唯一表达的那些,
2)丰富度不同的,以及3)不同的
以类似的方式监管,以回应EGF。一种比较
在EGF反应基因的类别中提供了一种开始
对监管中的重要内容进行系统分析
对细胞增殖的影响。对基因克隆的仔细分析
将被用来区分EGF调节的基因
被刺激的、被抑制的或无反应的细胞所特有的
EGF。当所需类型的候选cdna克隆
获取后,它们将用于检查正常和其他
转化的细胞对EGF有反应。有了这样的探测器,
将启动研究以识别编码基因并
考察表皮生长因子调节其功能的机制(S)
在正常细胞和转化细胞中均有表达。
英文摘要
The mechanism by which epidermal growth factor (EGF) and other
peptide hormones influence cellular growth control are unknown.
Most efforts to isolate and identify EGF responsive genes have
focused on the early phases of the EGF response. However, the
earliest responses are not sufficient to elicit a growth response
since EGF must be present continuously for a prolonged period
(over 6-12 hours) before commitment occurs. During this time
the cells undergo a large number of metabolic changes. It has
proven difficult to distinguish those events which are involved in
cellular activation from those required for commitment to, or
stimulation of cell division. To avoid this problem, genetically
related cloned cell lines which differ in their growth response to
EGF (stimulated, unresponsive or inhibited) will be used to isolate
cDNAs to EGF responsive genes. Although the biological response
to EGF is different in each cell type, many of the early responses
elicited by EGF are similar in the differentially responsive cloned
cell lines; eg. the EGF-receptors are similar in their binding
affinity for EGF, the extent of tyrosine phosphorylation elicited
by the hormone and the rate and extent of receptor
internalization. Large and representative lambda gt10 cDNA
libraries were made with cDNA synthesized from each cell clone
type treated with EGF for defined intervals. The libraries will be
screened with cDNA probes prepared by subtractive hybridization
to enrich for sequences specific to the EGF response of each cell
clone type. Subtractive hybridization cDNA probes will be used
to enrich for EGF responsive sequences which can be categorized
as follows: 1) those uniquely expressed in each cloned cell type,
2) those which differ in abundance, and 3) those which are
regulated in a similar manner in response to EGF. A comparison
of the classes of EGF responsive genes provide a means to begin a
systematic analysis of those which are important in the regulation
of cellular proliferation. A careful analysis of the cDNA clones
will be used to distinguish the EGF regulated genes which are
specific to cells stimulated by, inhibited by or non-responsive to
EGF. When candidate cDNA clones of the desired types are
obtained, they will be used to examine normal and other
transformed cells responding to EGF. With such probes in hand,
studies will be initiated to identify the encoded genes and to
examine the mechanism(s) by which EGF regulates their
expression in both normal and transformed cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE L-ARGININE: NO PATHWAY IN MAMMARY TUMOR PROGRESSION
-
批准号:6342166
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2000
-
负责人:Carol L. MacLeod
-
依托单位:
THE L-ARGININE: NO PATHWAY IN MAMMARY TUMOR PROGRESSION
-
批准号:6489305
-
项目类别:
-
资助金额:$39.81万
-
财政年份:2000
-
负责人:Carol L. MacLeod
-
依托单位:
THE L-ARGININE: NO PATHWAY IN MAMMARY TUMOR PROGRESSION
-
批准号:6045408
-
项目类别:
-
资助金额:$26.99万
-
财政年份:2000
-
负责人:Carol L. MacLeod
-
依托单位:
THE L-ARGININE: NO PATHWAY IN MAMMARY TUMOR PROGRESSION
-
批准号:6626702
-
项目类别:
-
资助金额:$41.39万
-
财政年份:2000
-
负责人:Carol L. MacLeod
-
依托单位:
TRANSPORTER OF AMINO ACIDS, PEPTIDES AND MONOAMINES
-
批准号:2373264
-
项目类别:
-
资助金额:$2.37万
-
财政年份:1997
-
负责人:Carol L. MacLeod
-
依托单位:
PATHOLOGICAL & NORMAL FUNCTION OF A NOVEL HOMEOBOX GENE
-
批准号:2098307
-
项目类别:
-
资助金额:$0.52万
-
财政年份:1993
-
负责人:Carol L. MacLeod
-
依托单位:
PATHOLOGICAL AND NORMAL FUNCTION OF A NOVEL HOMEBOX GENE
-
批准号:3201933
-
项目类别:
-
资助金额:$23.03万
-
财政年份:1993
-
负责人:Carol L. MacLeod
-
依托单位:
PATHOLOGICAL & NORMAL FUNCTION OF A NOVEL HOMEOBOX GENE
-
批准号:2098310
-
项目类别:
-
资助金额:$0.32万
-
财政年份:1993
-
负责人:Carol L. MacLeod
-
依托单位:
PATHOLOGICAL & NORMAL FUNCTION OF A NOVEL HOMEOBOX GENE
-
批准号:2098309
-
项目类别:
-
资助金额:$22.36万
-
财政年份:1993
-
负责人:Carol L. MacLeod
-
依托单位:
PATHOLOGICAL AND NORMAL FUNCTION OF A NOVEL HOMEBOX GENE
-
批准号:2098308
-
项目类别:
-
资助金额:$2.26万
-
财政年份:1993
-
负责人:Carol L. MacLeod
-
依托单位:
PATHOLOGICAL & NORMAL FUNCTION OF A NOVEL HOMEOBOX GENE
-
批准号:2098311
-
项目类别:
-
资助金额:$23.39万
-
财政年份:1993
-
负责人:Carol L. MacLeod
-
依托单位:
PATHOLOGICAL & NORMAL FUNCTION OF A NOVEL HOMEOBOX GENE
-
批准号:2376869
-
项目类别:
-
资助金额:$24.33万
-
财政年份:1993
-
负责人:Carol L. MacLeod
-
依托单位:
PATHOLOGICAL AND NORMAL FUNCTION OF A NOVEL HOMEBOX GENE
-
批准号:2098306
-
项目类别:
-
资助金额:$22.0万
-
财政年份:1993
-
负责人:Carol L. MacLeod
-
依托单位:
EGF RESPONSIVE GENES WHICH REGULATE TUMOR CELL GROWTH
-
批准号:3183919
-
项目类别:
-
资助金额:$12.23万
-
财政年份:1987
-
负责人:Carol L. MacLeod
-
依托单位:
EGF RESPONSIVE GENES WHICH REGULATE TUMOR CELL GROWTH
-
批准号:3183917
-
项目类别:
-
资助金额:$13.95万
-
财政年份:1987
-
负责人:Carol L. MacLeod
-
依托单位:
SL12 T-LYMPHOMA: A NEW MODEL FOR GENE CONTROL IN TUMORS
-
批准号:2089427
-
项目类别:
-
资助金额:$25.76万
-
财政年份:1984
-
负责人:Carol L. MacLeod
-
依托单位:
SL12 T-LYMPHOMA: A NEW MODEL FOR GENE CONTROL IN TUMORS
-
批准号:3175594
-
项目类别:
-
资助金额:$13.59万
-
财政年份:1984
-
负责人:Carol L. MacLeod
-
依托单位:
SL12 T-LYMPHOMA: A NEW MODEL FOR GENE CONTROL IN TUMORS
-
批准号:3175595
-
项目类别:
-
资助金额:$14.51万
-
财政年份:1984
-
负责人:Carol L. MacLeod
-
依托单位:
SL12 T-LYMPHOMA: A NEW MODEL FOR GENE CONTROL IN TUMORS
-
批准号:3175590
-
项目类别:
-
资助金额:$21.69万
-
财政年份:1984
-
负责人:Carol L. MacLeod
-
依托单位:
SL12 T-LYMPHOMA--A NEW MODEL FOR GENE CONTROL IN TUMORS
-
批准号:3175598
-
项目类别:
-
资助金额:$24.27万
-
财政年份:1984
-
负责人:Carol L. MacLeod
-
依托单位:
海外基金